| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NUPLAZID | 207318 | 001 | NDA | PIMAVANSERIN TARTRATE | TABLET;ORAL | EQ 17MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | Yes | No | 2016/04/29 | 2016/04/29 | ACADIA PHARMS INC | Discontinued |
| NUPLAZID | 207318 | 002 | NDA | PIMAVANSERIN TARTRATE | TABLET;ORAL | EQ 10MG BASE | Yes | Yes | 2016/04/29 | 2018/06/28 | ACADIA PHARMS INC | Prescription |
| NUPLAZID | 210793 | 001 | NDA | PIMAVANSERIN TARTRATE | CAPSULE;ORAL | EQ 34MG BASE | Yes | Yes | 2018/06/28 | 2018/06/28 | ACADIA PHARMS INC | Prescription |